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Abstract
A human bone marrow-derived mesenchymal stromal cell (MSCs) and cord blood-derived
CD34+ stem cell co-culture system was set up in order to evaluate the proliferative and dif-
ferentiative effects induced by MSCs on CD34+ stem cells, and the reciprocal influences on
gene expression profiles. After 10 days of co-culture, non-adherent (SN-fraction) and adher-
ent (AD-fraction) CD34+ stem cells were collected and analysed separately. In the presence
of MSCs, a significant increase in CD34+ cell number was observed (fold increase = 14.68),
mostly in the SN-fraction (fold increase = 13.20). This was combined with a significant
increase in CD34+ cell differentiation towards the BFU-E colonies and with a decrease in
the CFU-GM. These observations were confirmed by microarray analysis. Through gene
set enrichment analysis (GSEA), we noted a significant enrichment in genes involved in
heme metabolism (e.g. LAMP2, CLCN3, BMP2K), mitotic spindle formation and proliferation
(e.g. PALLD, SOS1, CCNA1) and TGF-beta signalling (e.g. ID1) and a down-modulation of
genes participating in myeloid and lymphoid differentiation (e.g. PCGF2) in the co-cultured
CD34+ stem cells. On the other hand, a significant enrichment in genes involved in oxygen-
level response (e.g. TNFAIP3, SLC2A3, KLF6) and angiogenesis (e.g. VEGFA, IGF1, ID1)
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was found in the co-cultured MSCs. Taken together, our results suggest that MSCs can
exert a priming effect on CD34+ stem cells, regulating their proliferation and erythroid differ-
entiation. In turn, CD34+ stem cells seem to be able to polarise the BM-niche towards the
vascular compartment by modulating molecular pathways related to hypoxia and
angiogenesis.
Introduction
Haematopoiesis is a continuous blood cell production process occurring in the bone marrow
niche (BM-niche) through the orchestrated proliferation, self-renewal and differentiation of
haematopoietic stem cells (HSCs) [1,2].
The mesenchymal stem/stromal cells (MSCs) play an essential role in the quiescence, prolif-
eration and differentiation of HSCs [3–5]. They are spatially associated with HSCs, adrenergic
nerve fibres and arteriolar vasculature and constitute a structurally unique niche made of
MSC-HSC pairings, tightly regulated by local input and long-distance cues [6–10].
The CXCL12(SDF-1)/CXCR4 axis is one of the most important biological mechanisms
involved in the reciprocal interaction between MSCs and HSCs [11,12]. Experimental data
indicate that in vivo nestin+ MSC depletion significantly reduces bone marrow homing and
haematopoietic progenitor content [13]. In a xenogenic transplantation model, MSCs favour
the haematopoietic engraftment by an increased expression of SDF-1 and osteopontin and,
when injected locally, they co-localised around blood vessels in the subendosteal region of
mice femurs, restoring BM-niche function even when the stroma is damaged [14].
The activation of specific signalling pathways, such as those dependent on Notch, Wnt/β-
catenin molecules [15] or on the adhesion molecules, (fibronectin-1, cadherin-11, vascular cell
adhesion molecule-1 (VCAM-1), CX43) and integrins [16] have been recognized to be
involved in the interaction between human HSCs and MSCs. The interaction of VCAM-1 with
integrin alpha4beta1 through which MSCs modulate the fate of HSCs [17]. Less known is the
role of alternative genes and signalling pathways that contribute to regulate stemness, cell pro-
liferation and cell differentiation.
These data strongly suggest that haematological recovery post-ablative chemotherapy or
after HSC transplantation depends on and could be improved by the co-operation between
MSCs and HSCs. In mice model, Me´ndez-Ferrer et al. observed that physical association
between nestin+MSCs and HSCs is essential to inducing the expression of HSC maintenance
genes and to balance HSC quiescence, proliferation and differentiation [13].
In humans, perhaps the best transplant model suggesting the potential role of MSCs in
favouring HSC proliferation and differentiation is allogeneic transplantation based on intra-
bone injection of cord blood haematopoietic stem cells (CB-CD34+ cells) (IB-HSCT) [18,19].
In this case, positive effects in the haematopoietic recovery observed in the transplanted
patients have been attributed to a local and direct interaction of the injected HSCs with other
cell components into the BM-niche, including, in particular, with MSCs.
The expectation that an intra-bone co-infusion of MSCs could promote the ability of BM-
niche in supporting the post-transplant haematopoiesis by contributing to the repair or
replacement of the stromal damage is intriguing but it is not explored. Furthermore, assuming
a possible in vivo use of MSC and HSC co-infusion, biological aspects regarding the effects of
the HSCs on MSCs have not been investigated at all. Since experimental data and comprehen-
sive indications suggesting that HSCs priming with MSCs could improve the clinical outcome
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in the setting of allogeneic HSCs transplantation are still lacking, we investigated how bone
marrow-derived MSCs can affect the molecular and functional phenotype of CB-CD34+ cells
and vice versa. To this end, we set up an ex-vivo human MSC-HSC co-culture system in order
to evaluate the early proliferative and differentiative effects induced by MSCs on HSCs, and
the reciprocal influences on their gene expression profiles.
Materials and methods
Ethics statement
Ethics approval to conduct this study was granted by Comitato Etico Provinciale della Provin-
cia di Brescia—ASST Spedali Civili di Brescia (Approval number: NP1871).
Experimental design
BM-derived MSCs (BM-MSCs, red) were seeded on a plastic support. Upon reaching 80% of
confluence, previously isolated CD34+ CB-derived HSCs (CB-CD34+ cells, blue) were plated
onto a MSCs layer. After 10 days of culture, cells grown in suspension were collected in plastic
tubes, while adherent cells were harvested by trypsinization. Two different fractions of HSCs
were obtained: the SN-fraction (green), representing the cells grown in the supernatant of the
co-cultures, and the AD-fraction (yellow), representing the cells grown directly in contact with
the stromal layer, represented by co-cultered MSCs (brown). Single cultures of BM-MSCs and
CB-CD34+ cells served as controls, namely MSCs-alone (orange) and CB-alone (light green)
(Fig 1).
CB-CD34+ cell purification
Fresh cord blood (CB) samples were collected after normal vaginal delivery in women without
infectious diseases or maternal complications, after informed written consent. Mononuclear
cells (MNC) were isolated from 30 ml of CB after density gradient centrifugation using lym-
phocytes separation media (Histopaque1, Sigma-Aldrich) stratification (2000 rpm, 20 min).
After washing with Phosphate-Buffered Saline (PBS) (Gibco), MNC were incubated with
immunomagnetic beads (CD34+) (Miltenyi) following manufacturer’s instruction. After
CD34+ cell recovery, cell purity was assessed by flow cytometry (FACS Canto II1, BD) using a
panel of CD34-PE and CD45-FITC (BD) fluorochrome-conjugated monoclonal antibodies.
TruCount1 Absolute-Count Tubes (BD) were used for determining the number of CD34
+ cells. The strategy of gating is reported in the S1 and S2 Figs. CB samples were processed
within 8 hours from collection; cells with at least 90% of purity were used for co-culture
experiments.
Isolation and characterization of BM-MSCs
Third party-MSCs were obtained from bag washouts after scheduled BM harvests according to
standards of National Marrow Donor Program and after informed written consent. The
Donor of BM-MSCs was a healthy 20 years old male. Total nucleated cells from filter and bag
residues were obtained after two washings with 100–150mL PBS and centrifugation at 200 g
for 10 min. The pellet material was gently resuspended in 20–30mL PBS and separated over
Histopaque1 gradients centrifugation to yield MNC. One million MNC were seeded in a T75
flask (Sarstedt) and cultured in complete ISCOVE’s modified Dulbecco’s medium (Gibco)
supplemented with 10% Fetal Bovine Serum (FBS) (Gibco). Medium was changed weekly, dis-
carding non-adherent cells. After 3 weeks, adherent cells were trypsinized and purity was
assessed by flow cytometry using a panel of the following antibodies: CD45-FITC, CD90-APC,
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CD73-PE, CD105-PerCP-Cy5.5 and 7AAD-PerCP (BD). MSCs were also characterized for
their differential potential. According to the manufacture’s instruction, cells were cultured in
proper media for adipogenic (Mesencult™ Adipogenic Differentiation Medium, StemCell
Technologies), chondrogenic (StemXVivo™ Chondrogenic Differentiation Media, R&D Sys-
tems) and osteogenic (Mesencult™ Osteogenic Stimulatory Kit, StemCell Technologies) differ-
entation, followed by staining with Oil-Red-O (Sigma Aldrich), Safranin O (Sigma Aldrich)
and Alizarin Red S (Sigma Aldrich), respectively. Briefly, 5x104 cells were plated in culture
dishes with weekly changing of the specific differentiating media. At the end of the differentia-
tion period, all cultures were fixed with 4% formaldehyde for 30 min and adipocytes were
stained with 0,3% Oil Red O solution for 10min; bone cells with 2% Alizarin Red S solution
(pH 4.2) for 3 min, while chondrogenic pellets were stained with 0.1% Safranin O solution for
5 minutes (S3 Fig). Once characterized, MSCs (CD45-, CD90+, CD73+, CD105+ cells> 95%)
were expanded and stored in liquid nitrogen at the final concentration of 0.5x106 cells/vial. In
this study, MSCs were used until third passage.
CB-CD34+ cells and BM-MSCs co-cultures
BM-MSCs were thawed at 37˚C and 1.5x106 cells were plated in three T75 flasks at equal con-
centrations (0.5x106 cells/flask). Cells were cultured in complete ISCOVE’s modified Dulbec-
co’s medium supplemented with 10% FBS for a week until 80% confluence.
CB-CD34+ cells were seeded directly onto the MSCs layer at a final concentration of
0.3x106 cells/flask. Cells were maintained in serum-free medium (StemSpan H3000, StemCell
Technologies) supplemented with 100 ng/ml Stem Cell Factor (SCF) (Peprotech), Thrombo-
poietin (TPO) (Peprotech) and Granulocyte Colony Stimulating Factor (G-CSF) (Italfarmaco)
for 10 days at 37˚C and 5% CO2.
A single co-culture experiment consisted of:
• 2 T75 of 0.3x106 CB-CD34+ cells seeded onto MSCs at 80% confluence (CB-CD34+ cells
and MSCs co-culture)
Fig 1. Experimental design of the study. See Material and method section for a complete description of the
figure. Ten days of culture were chosen for 2 reasons: first of all, the majority of research articles dealing with
MSCs and HSCs range from 7 to 14 days of co-culturing. Secondly, 10 days of co-culturing allow to see a
biological effect of MSCs on HSCs without inducing cellular senescence in stromal cells. Indeed, co-cultures
were maintained in serum-free medium supplemented with Stem Cell Factor (SCF), Thrombopoietin (TPO)
and Granulocyte Colony Stimulating Factor (G-CSF) (see below for details). When MSCs are cultured in this
medium for more than 14 days they undergo changes in cell morphology and they begin losing their
phenotypic characteristics (data not shown).
doi:10.1371/journal.pone.0172430.g001
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• 1 T75 of 0.3x106 CB-CD34+ cells (CB-CD34+ alone)
• 1 T75 of MSCs at 80% of confluence (MSCs alone)
As regards microarray experiments and clonogenic assay, three independent experiments
were performed, whereas for the evaluation of CB-CD34+ cell expansion, 5 independent repli-
cates were performed. In all the experiments, cord blood samples were never pooled
Purification and cell-sorting of BM-MSCs and CB-CD34+ cells
After 10 days of culture, cells grown in suspension were collected in plastic tubes, while adher-
ent cells were harvested by trypsinization. Four different cell fractions were obtained: the single
culture of CB-CD34+ cells grown in suspension (CB-alone), the single culture of MSCs grown
adherent to the flask (MSCs-alone), the CB-CD34+ cells in the co-culture supernatant (SN-
fraction) and the adherent fraction (AD-fraction) of the co-cultures, i.e. adherent MSCs and
CB-CD34+ cells grown directly in contact of the stromal layer. Samples were centrifuged 10’ at
1300 rpm, pellets were resuspended in PBS and stained for 30’ on ice with the following fluoro-
chrome-conjugated monoclonal antibodies: CD45-FITC (BD Biosciences), CD73-PE (BD Bio-
sciences), CD90-PE (BD Biosciences), CD105-PE (ImmunoStep), CD34-APC (BD
Biosciences), in presence of DAPI (Sigma-Aldrich). Cells were then washed, passed through a
45 um cell strainer (BD Biosciences) and resuspended in PBS. Stained cells were analyzed and
sorted by a FACSAria II flow cytometer (Becton Dickinson). Flow cytometric data were ana-
lyzed using FACSDiva software (Becton Dickinson). Dead cells and debris were excluded by
forward scatter (FSC), side scatter (SSC), and DAPI viability dye. MSCs were identified on the
basis of CD73, CD90, CD105 co-expression and lack of CD45. CB-CD34+ cells were identified
on the basis of CD45 and CD34 co-expression. At least 0.3x106 gated events were acquired for
each sample. Purity of FACS-isolated cells was greater than 95%, as assessed by flow cytometric
analysis of post-sorting samples.
Proliferation and clonogenic assays of CB-CD34+ cells
The proliferation of CB-CD34+ cells was reported as a fold-increase ratio by comparing the
number of CB in the Total SN+AD (CD34+ cells grown in presence of MSCs) with the number
of CD34+ cells of CB-alone, thus obtaining a readout of the effect of MSCs on the proliferative
capacity of the CB-CD34+ cells. Similarly, we reported the fold-increase ratio of CB-CD34
+ cells grown in the SN-fraction and in the AD-fraction independently analyzed. We per-
formed 5 independent experiments to achieve statistical significance. The number of human
Colony Forming Units (CFUs) of CB-CD34+ cells was analyzed by seeding 1x103 CD34+ cells
of CB-, SN- and AD- fractions, respectively, in a 35 mm dish (Sarstedt). Seeded cells were cul-
tured in MethoCult™ H4535 methylcellulose media (StemCell Technologies) at 37˚C, in
humidified atmosphere and 5% CO2. After 14 days, the number of erythroid burst-forming
unit (BFU-E), granulocyte-macrophage colony forming unit (CFU-GM) and granulocyte/
erythrocyte/macrophage/megakaryocyte colony forming unit (CFU-GEMM) was determined
with manual count at optical microscope. Values came from three replicates.
RNA extraction and microarray analysis
Total cellular RNA was isolated using Qiagen total RNA purification kits as recommended by
the manufacturer (Qiagen). RNA integrity, purity and concentration were then verified by the
Bio-Analyzer technique (Applied Biosystem) and NanoDrop 2000 spectrophotometer (Life
Technologies). Three independent experiments for each culture condition were performed.
An amount of 50 ng of RNA was converted in labelled aRNA using the GeneChip 3’ IVT
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Expression kit (Affymetrix) and then used to hybridized the Affymetrix HG-U133A PLUS 2.0
GeneChip arrays that were subsequently washed and stained using the GeneChip Hybridiza-
tion, Wash and Stain Kit (Affymetrix). Genechips were then analyzed with the Affymetrix
Scanner 3000 and the images obtained were processed by Microarray Analysis Suite 5.0 (MAS
5.0) algorithm. Hybridization quality, absolute call (absent or present) and mRNA quantifica-
tion were also evaluated.
The complete dataset has been submitted to the gene expression omnibus data (GEO) pub-
lic database at NCBI, and the accession number is GSE90970.
Gene validation by quantitative RT-PCR
Quantitative RT-PCR (qRT-PCR) was carried out by a Light Cycler 480 sequence detection
system (Roche Diagnostics) on total RNAs (100 ng) reversely transcribed using the High
Capacity cDNA Archive Kit (Applied Biosystems), according to the manufacturer’s instruc-
tions. Each cDNA sample was run in duplicate for either each target (VEGFA and CCNA1) or
GAPDH endogenous control. TaqMan gene assays, supplied as ready solutions, and TaqMan
Universal PCR Master Mix were provided by Applied Biosystems. Quantification of qRT-PCR
signals was performed using the (2-Delta DeltaCt) method [20], which calculates relative changes
in gene expression of the target gene normalized to the GAPDH endogenous control and rela-
tive to a calibrator sample. The values obtained were represented as relative quantity of mRNA
level variations.
Bioinformatic analysis
Number of CB-CD34+ cells and clonogenicity assays were presented as mean ± standard devi-
ations (SDs) and analyzed using Student’s t-test. Differences between the samples were consid-
ered statistically significant for p<0.05.
Microarrays data were processed by using Partek1 Genomics Suite1 software to identify
genes differentially expressed in MSCs and CB-CD34+ cells following co-culture. The lists of
genes were obtained by applying multiple comparison tests (Bonferroni’s correction and False
Discovery Rate) after ANOVA analysis, and only genes with a fold change<-2 or> +2 were
selected.
The analysis of molecular pathways was carried out as previously reported [21–24]. Briefly,
EASE software was applied to establish whether specific cell functions and biological processes,
defined according to gene ontology, were significantly represented among the deregulated
genes through the DAVID Functional Annotation Bioinformatics Microarray Analysis
[25,26]. Broad Institute Gene Set Enrichment Analysis (GSEA) software was performed to
identify significant enrichments in differentially expressed genes signatures, in case of nominal
P values corrected for False Discovery Rate (FDR) for enrichment scores minor than 0.05. Spe-
cifically, GeneOntology Biological Processes, Oncogenic pathways, immune pathways, and
curated gene sets were considered [27]. The network analyses were generated through the use
of Ingenuity Pathway Analysis1 (IPA1, Qiagen).
Results
Co-cultures of CB-CD34+ cells and MSCs
Co-culturing experiments were performed to evaluate the MSCs’ effects on the proliferation
and differentiation of CB-CD34+ cells. After 10 days, when cultured alone (CB-alone), 0.5x106
CB-CD34+ cells were obtained. The ratio of CD34+ cells grown in single culture (CB-alone)
was compared to the total number of CD34+ cells after co-culture with MSCs (Total SN+AD).
Effects of MSCs and CB-CD34+ cell interaction
PLOS ONE | DOI:10.1371/journal.pone.0172430 February 23, 2017 6 / 19
A fold-increase of 14.68 (median of 5 replicates, p = 0.019) was found. Notably, a 13.20-fold
increase in the number of CD34+ cells was observed with the sorted SN-fraction (median of 5
replicates, p = 0.025), while no statistically significant difference was found with the sorted
AD-fraction. Data are summarised in Fig 2 and in S1 Table.
The colony-forming unit ability of CB-CD34+ cells was investigated by performing a clono-
genic assay in methylcellulose-based cultures. A statistically significant difference in clono-
genic capacity was found by comparing CB-alone-derived colonies with the co-culture-
derived colonies (Total SN+AD, SN-fraction or AD fraction alone). In particular, the methyl-
cellulose-based assay showed no statistically significant differences in CFU-GEMM number,
while a significant increase in the BFU-E colonies was observed in co-culture-derived fractions
(Total SN+AD p<0.01, SN-fraction p<0.05 or AD-fraction p<0.05), and this was combined
with a decrease in the CFU-GM, in the SN-fraction only (p<0.05). Data are shown in Fig 3.
Gene expression profiling of CB-CD34+ cells after co-culture with MSCs
CB-CD34+ cells, either cultured alone or with MSCs (Total SN+AD, SN-fraction or AD-frac-
tion alone), were analysed for their gene expression profile by using GeneChip arrays
HG-U133A 2.0 PLUS (Affymetrix). First, gene expression profiles of SN-fraction vs. AD-frac-
tion were analysed to assess possible differences in their transcriptomes. Since no statistically
significant differences were found between SN- and AD- fractions (data not shown), CB-alone
and Total SN+AD (SN- and AD- fractions together) were compared.
Seventy-one out of 47,000 genes spotted on the array were expressed differentially, with a
corrected p<0.05 coupled with a fold change< -2 or > +2. Based on the expression of such 71
genes, CB-alone and culture-derived cells (AD+SN) appeared clearly distinct (Fig 4A).
Fig 2. Ex vivo expansion of CB-CD34+ cells with MSCs. 5×105 CB-CD34+ cells were cultured alone or in
presence of a layer of MSCs for 10 days; the fold increase in total cell number was calculated from the original
CD34+ cells seeded at day 0. The absolute number of CB-CD34+ cells was measured by flow cytometry.
Values came from 5 independent replicates. Abbreviation: CB-alone: number of CB-CD34+ cells after 10
days of single culture; SN-fraction: CB-CD34+ cells in the supernatant (SN-fraction) of the co-cultures with
MSCs; AD-fraction: CB-CD34+ cells grown directly in contact with MSCs layer; Total SN+AD: total number of
CB-CD34+ cells after co-culture with MSCs.
doi:10.1371/journal.pone.0172430.g002
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To understand better the possible biological role of the transcriptional differences induced
by culture, we investigated whether the identified gene signature was enriched with genes
involved in specific cellular programs and functions. Through gene set enrichment analysis
(GSEA), we found a significant enrichment in genes involved in heme metabolism, mitotic
spindle formation and proliferation, and TGF-beta signalling (Fig 4B, S2 Table). In addition,
IPA-based pathway analysis revealed the significant involvement of genes regulating cell-to-
cell signalling, haematological system development and function, cell cycle, growth and prolif-
eration (S3 Table). In particular, certain genes (e.g. ID1 and PCGF2) appeared to be key regula-
tors of several processes affecting haematopoiesis (S4–S6 Figs). To confirm the microarray
data, qRT-PCR was carried out on CCNA1 that resulted differentially expressed between CB-
alone versus SN-fraction and AD-fraction. Data related to the relative quantity of mRNA level
variations are recorded in Fig 5.
Gene expression profiles analysis of MSCs after co-culturing with
CB-CD34+ cells
Co-culture effects on MSC transcriptome were then studied. To this aim, microarray analysis
was carried out on either MSCs-alone or MSCs maintained for 10 days in co-culture with
Fig 3. Clonogenic assays of CB-CD34+ cells. Results of statistical analysis of methylcellulose-based
clonogenic assay performed on CB-CD34+ cells plated after 14 days of co-culture with human MSCs. (A)
CFU-GEMM count; (B) BFU-E count; (C) CFU-GM count. Values are reported as mean ±SD. The results derive
from three independent experiments. Abbreviations: BFU-E, Burst forming unit-erythroid; CFU, Colony forming
unit; E, erythrocyte; GM, granulocyte-monocyte; GEMM, granulocyte-erythrocyte-monocyte-megakaryocyte.
doi:10.1371/journal.pone.0172430.g003
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CB-CD34+ cells. In the latter case, only MSC samples with at least 95% purity following cell
sorting were used.
Five-hundred-ninety-seven genes were expressed differentially in untreated vs. cultured
MSCs with a corrected p<0.05 and a fold change< -2 or> +2. The two cell populations were
clearly separated as suggested by hierarchical clustering based on the expression of these genes
(Fig 6A).
Again, to explore the potential biological role associated with the transcriptional changes,
GSEA and pathway analyses were performed. Among others, we found a significant enrich-
ment in genes involved in angiogenesis and VEGF signalling, proliferation and aurora kinase
B activity, and NF-kappa B pathway (Fig 6B, S4 Table), as well as genes involved in cell-to-cell
signalling and interaction, cell cycle, and cardiovascular system development and function (S7
and S8 Figs; S5 Table).
Among the genes differentially expressed in MSCs-alone vs. co-cultured MSCs, VEGFA
was used as validating gene of microarray data. QRT-PCR analysis confirmed a significant
VEGFA up-regulation following co-culture of MSCs and HSCs (Fig 7).
Fig 4. Gene expression analysis of CB-CD34+ cells after co-culture with MSCs. (A) Supervised analysis
of CB-alone vs. Total SN+AD. CB-CD34+ cells were maintained for 10 days in co-culture with MSCs. A heat
map of the genes differentially expressed in a statistically significant manner after co-culture (corrected p
value <0.05) is plotted. (B) Gene Set Enrichment Analysis (GSEA) of CB-alone vs Total SN+AD. Enriched
gene sets from hallmark gene sets are plotted. Please refer to S2 Table for the complete GSEA details.
Abbreviation: CB-alone: CB-CD34+ cells in single culture; Total SN+AD: CB-CD34+ cells grown in presence
of MSCs.
doi:10.1371/journal.pone.0172430.g004
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Discussion
MSCs are essential for HSC self-renewal and proliferation [28–30] and, in the case of
IB-HSCT, it has been suggested that they can favour haematologic recovery by interacting
with CB-CD34+ cells when injected locally into the BM [31,32]. Nevertheless, experimental
data and comprehensive indications suggesting that HSCs priming with MSCs could improve
the clinical outcome in the setting of allogeneic HSCs transplantation are still lacking. For this
purpose, we investigated how bone marrow-derived MSCs can affect the molecular and func-
tional phenotype of CB-CD34+ cells and vice versa. To this end, we set up a co-culture system
of human CB-CD34+ cells with third-party MSCs to elucidate the mechanisms depending on
the early reciprocal interaction between MSCs and HSCs.
In presence of BM-MSCs, a significant increase in CB-CD34+ cell proliferation (fold
increase of 14.68, p = 0.019) was observed as compared to the CB-CD34+ cells cultured alone.
Since the increase was mainly observed in the SN-fraction (fold increase of 13.20, p = 0.025),
we supposed that the inductive proliferative effects of MSCs on HSCs could be mediated by
MSCs-derived molecules. We did not carry out a systematic and complete study of secretome.
It has been already reported that several cytokines and growth factors, such as SDF-1, stem cell
factor (SCF), Flt-3 ligand (FL), thrombopoietin (TPO), interleukin (IL)-6, IL-11, tumor necro-
sis factor-alpha (TNF-alpha), and transforming growth factor-beta 1 (TGF-beta1), are involved
in inducing proliferative effects on HSCs [33]. We looked at the levels of TNF-alpha, inter-
feron-gamma, IL-8, IL-6, sVCAM-1 and sICAM-1 in the supernatant of the cultures, and at
the end of 10 days of co-culture, we did not find a significant increase in the levels of the above-
mentioned cytokines in the co-culture medium, even though higher detectable levels of TNF-
alpha, IL-6 and sVCAM-1 were present (data not shown). Although a possible partial degrada-
tion of these cytokines cannot be excluded, our results suggest that their production was not
induced by co-culturing. This observation is not in contrast with that which has been reported
in a number of studies published in recent years [34–40]. The majority of these studies did not
specify whether the inductive proliferative effects of MSCs on HSCs depended on direct con-
tact with MSCs or mediation by soluble molecules. Furthermore, they did not provide any
information regarding HSC differentiation, as well as gene expression profiles. Alakel et al.
investigated the impact of direct contact between MSCs and HSCs in terms of expansion, dif-
ferentiation, migratory capacity, and gene expression profile [41]. However, they used
Fig 5. Real-Time Quantitative Polymerase Chain Reaction PCR (qRT-PCR) analysis of CCNA1 gene.
Expression level of CCNA1 gene was assessed by qRT-PCR. Quantification of mRNA relative quantity was
calculated as relative changes in gene expression of the target gene normalised to the GAPDH endogenous
control and relative to a calibrator sample. The values obtained were represented as relative quantity of
mRNA level variations.
doi:10.1371/journal.pone.0172430.g005
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mobilised CD133+ haematopoietic progenitor cells from healthy adult donors instead of
CB-CD34+ cells collected after natural delivery, thereby introducing the granulocyte colony-
stimulating factor (G-CSF) treatment as a variable. Nevertheless, their results are superimpos-
able with ours; in particular, they observed that when CD133+ cells were grown in the pres-
ence of MSCs, there was a significant increase in the number of haematopoietic progenitor
cells and an increase in the number BFU-E colonies. Moreover, when they performed gene
expression analysis between non-adherent and adherent fractions, they observed a modulation
in genes involved in cell-to-cell and cell-to-extracellular matrix contact, cell cycle and some
signalling pathways. Interestingly, just like Alakel et al. in their study, we found that co-cul-
tured CB-CD34+ cells were first induced by MSCs towards erythroid commitment. On the
other hand, we did not observe an inductive differentiation effect on CFU-GM. We do not
have a clear explanation as to why the BFU-E differentiation was favoured as compared to
CFU-GEMM and CFU-GM. In this regard, we can only speculate that the preferential shift
Fig 6. Gene expression profiles analysis of MSCs after co-culturing with CB-CD34+ cells. (A)
Supervised analysis of MSCs-alone vs. MSCs after 10 days of co-culture with CB-CD34+ cells. A heat map of
the genes differentially expressed in a statistically significant manner after co-culture (corrected p value
<0.05) is plotted. (B) Gene Set Enrichment Analysis (GSEA) of MSCs-alone vs. MSCs maintained for 10 days
in co-culture with CB-CD34+ cells. Top 10 gene sets from hallmark gene sets, canonical/KEGG pathways and
oncogenic signatures are plotted. Please refer to S4 Table for the complete GSEA details.
doi:10.1371/journal.pone.0172430.g006
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towards erythroid commitment is a priority and thus the first and more important step for ini-
tiating new haematopoietic reconstitution. In this regard, Alakel et al. also did not provide a
clear explanation of this phenomenon.
The increased capacity of proliferation and the preferential erythroid differentiation of
CB-CD34+ cells co-cultured with MSCs were confirmed by gene expression profile analysis.
IPA-based pathway analysis revealed significant involvement of genes regulating cell-to-cell
signalling (e.g. ARHGEF2,DGKE) [42,43], haematological system development and function
(e.g. TPP2, HOXA9, SOS1) [44–46], cell cycle, growth and proliferation (e.g. AIM2, BMP2K,
ZNRF3) [47,48]. In particular, genes such as ID1 and PCGF2 should be deemed relevant since
they are recognised to be the key regulators of several processes affecting haematopoiesis [49–
51]. Furthermore, the higher expression of CCNA1 gene, which encodes for cyclin A1, a master
regulator of the cell cycle [52], would confirm the higher proliferation rate of HSCs in the pres-
ence of MSCs. The enrichment in genes involved in erythroid differentiation (e.g. LAMP2,
CLCN3, BMP2K and SLC30A1) [53–56] and down-modulation of genes participating to mye-
loid and lymphoid differentiation (e.g. ID1, PCGF2) [57,58] are in accordance with the prefer-
ential shift of HSCs towards the erythroid commitment observed in the clonogenic assays.
Interestingly, bioinformatic analysis did not reveal a modulation of genes encoding haemoglo-
bin proteins (such as HBA1, HBA2, HBB, HBG1, HBG2). This could be explained by the fact
that gene expression profile analyses in co-cultured CB-CD34+ cells were performed after cell
sorting on the basis of CD45 and CD34 expression. In this setting, only immature haemato-
poietic progenitors were examined. Since genes encoding haemoglobin proteins get expressed
during erythrocyte differentiation, it is unlikely to record their statistically significant differ-
ences in terms of gene expression. Indeed, only HBB gene showed a borderline significant
trend (FDR = 0.08, fold change = 1.2).
Not only did the MSCs reveal to be able to modulate both the expansion of CB-CD34+ cells
(particularly in the SN-fraction) and the commitment towards erythroid lineage, but it was
also found that HSCs influence MSCs behaviour. Unlike Alakel’s study, where authors fucused
on hematopoietic compartment only, we also performed a deep characterization of the stromal
component. Interestingly, MSCs co-cultured with CB-CD34+ cells revealed a modulation of
genes involved in molecular pathways related to hypoxia and oxygen-level response (e.g.
TNFAIP3, SLC2A3, KLF6) and also a profound modification of pathways involved in angio-
genesis and vascular processes (e.g. VEGFA, IGF1, ID1) [59–64], as well as mTORC1 [65,66]
Fig 7. Real-Time Quantitative Polymerase Chain Reaction PCR (qRT-PCR) analysis of VEGFA gene.
Expression level of VEGFA in co-cultured MSCs was assessed by qRT-PCR. Quantification of mRNA relative
quantity was calculated as relative changes in gene expression of the target gene normalised to the GAPDH
endogenous control and relative to a calibrator sample. The values obtained were represented as relative
quantity of mRNA level variations as compared to MSCs-alone.
doi:10.1371/journal.pone.0172430.g007
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and Aurora kinases A and B [67,68]. Among these genes, VEGFA is one of the most intriguing
because it is an inducible growth factor that stimulates the formation of new blood vessels in
response to hypoxia, and it is one of the mechanisms by which MSCs can be involved in tissue
regeneration [69–71]. In particular, VEGFA is reported to stimulate postnatal haematopoiesis
[72] and to make stem cells resistant to an ischemic environment they would encounter after
transplantation into injured tissue and it improves the survival of both the transplanted cells
and the host cells at the injury site [73]. The qRT-PCR analysis on VEGFA confirmed its up-
regulation, in agreement with the microarray results. These data are thus indicative of a bi-
directional interaction between CB-CD34+ cells and MSCs that would favour the remodelling
of the BM-niche structure, and underline the importance of a switch from the osteogenic to
the vascular compartment in transplantation.
Conclusion
Taken all together, our results suggest that MSCs can exert a priming effect on CB-CD34
+ cells, possibly by secreting specific molecules essential to the regulation of HSC proliferation
and erythroid differentiation. In turn, CB-CD34+ cells seem to be able to polarise the BM-
niche towards the vascular compartment by modulating molecular pathways related to hyp-
oxia and angiogenesis. From a clinical point of view, since it is known that in the allo-trans-
planted patients MSCs may decrease by up to 90% and that this reduction is correlated to a
defective haematopoietic reconstitution [74], these data would suggest that a co-infusion of
MSCs with CB-CD34+ cells may favour the haematological recovery after IB-HSCT, possibly
by replacing damaged stroma and by promoting HSC engraftment through the remodelling
the BM-niche from the osteogenic compartment to the vascular one.
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